The Daily Mail reports on Denver, Colorado, which it describes as a hotspot for weight-loss drug use, claiming Ozempic and similar GLP-1 medications have become so widespread among wealthy residents that some women, including private-school mothers, have become dangerously thin. The article frames the city's affluent, health-conscious culture as fuelling excessive reliance on the drugs, raising concerns about misuse beyond their intended medical purpose and the emergence of a black market for obtaining them.

The piece links Denver's mountainous, fitness-focused lifestyle and wealth to a surge in demand for weight-loss injections, suggesting the drugs are being used for cosmetic weight loss rather than managing diabetes or obesity as originally intended. It also touches on concerns about unregulated or black-market access to the medications, though the article provides limited concrete data or medical sourcing to substantiate the scale of the described "abuse".